Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence

Genomic studies of cannabis use disorders have been limited. The cannabinoid receptor 1 gene (CNR1) on chromosome 6q14‐15 is an excellent candidate gene for cannabis dependence due to the important role of the G‐protein coupled receptor encoded by this gene in the rewarding effects of Δ9‐tetrahydrocannabinol. Previous studies have found equivocal evidence for an association between SNPs in CNR1 and a general vulnerability to substance use disorders. We investigate the association between 9 SNPs spanning CNR1 and cannabis dependence in 1,923 individuals. Two SNPs that were previously associated with cannabis dependence in other studies were also significant with this phenotype in our analyses [rs806368 (P = 0.05) and rs806380 (P = 0.009)]. Haplotype analyses revealed the association to be largely driven by the SNP rs806380. These results suggest a role for the cannabinoid receptor 1 gene in cannabis dependence. © 2008 Wiley‐Liss, Inc.

[1]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  Vernell S. Williamson,et al.  Cannabinoid receptor 1 gene association with nicotine dependence. , 2008, Archives of general psychiatry.

[3]  Joseph P. Schacht,et al.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1. , 2008, Archives of general psychiatry.

[4]  Scott F. Saccone,et al.  An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. , 2008, Archives of general psychiatry.

[5]  M. Nides Update on pharmacologic options for smoking cessation treatment. , 2008, The American journal of medicine.

[6]  A. Benyamina,et al.  Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence , 2008, Expert review of neurotherapeutics.

[7]  P. Goya,et al.  CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications. , 2008, Current Topics in Medicinal Chemistry.

[8]  Scott F. Saccone,et al.  Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. , 2008, Drug and alcohol dependence.

[9]  J. Gelernter,et al.  CNR1 Variation Modulates Risk for Drug and Alcohol Dependence , 2007, Biological Psychiatry.

[10]  M. Ussher,et al.  Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. , 2007, The Cochrane database of systematic reviews.

[11]  K. Bucholz,et al.  A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. , 2007, Addiction.

[12]  S. Purcell,et al.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[13]  J. Copeland Cannabis use, depression and public health. , 2006, Addiction.

[14]  B. Grant,et al.  Cannabis use disorders in the USA: prevalence, correlates and co-morbidity , 2006, Psychological Medicine.

[15]  J. Gelernter,et al.  Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[16]  A. Agrawal,et al.  The genetic epidemiology of cannabis use, abuse and dependence. , 2006, Addiction.

[17]  Christopher P Cannon,et al.  Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors , 2006, Expert opinion on investigational drugs.

[18]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[19]  B. Grant,et al.  Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. , 2005, The Journal of clinical psychiatry.

[20]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[21]  G. Uhl,et al.  Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse , 2004, Molecular Psychiatry.

[22]  B. Grant,et al.  Prevalence of Marijuana Use Disorders in the United States Design, Setting, and Participants Face-to-face Interviews Were Conducted in 2 , 2022 .

[23]  F. Dudbridge Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[24]  G. Uhl,et al.  Endocannabinoids and cannabinoid receptor genetics , 2002, Progress in Neurobiology.

[25]  M. Tsuang,et al.  The Harvard Twin Study of Substance Abuse: what we have learned. , 2001, Harvard review of psychiatry.

[26]  J. Gelernter,et al.  Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence , 2001, Molecular Psychiatry.

[27]  D. Heller,et al.  The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users , 2001, Addiction biology.

[28]  E R Martin,et al.  Letter to the Editor Correcting for a Potential Bias in the Pedigree Disequilibrium Test , 2022 .

[29]  V. Hesselbrock,et al.  The Collaborative Study on the Genetics of Alcoholism , 2001, Journal of Biomedical Science.

[30]  D. Collier,et al.  No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population , 2000, Molecular Psychiatry.

[31]  M. Hesselbrock,et al.  A validity study of the SSAGA--a comparison with the SCAN. , 1999, Addiction.

[32]  K. Merikangas,et al.  Familial transmission of substance use disorders. , 1998, Archives of general psychiatry.

[33]  L. Bierut,et al.  Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. , 1998, Archives of general psychiatry.

[34]  K. Kendler,et al.  Cannabis use, abuse, and dependence in a population-based sample of female twins. , 1998, The American journal of psychiatry.

[35]  J R O'Connell,et al.  PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.

[36]  B. Grant,et al.  Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. , 1995, Journal of substance abuse.

[37]  R. Mechoulam,et al.  Search for endogenous ligands of the cannabinoid receptor. , 1994, Biochemical pharmacology.

[38]  J. Nurnberger,et al.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. , 1994, Journal of studies on alcohol.

[39]  M. Boehnke,et al.  Allele frequency estimation from data on relatives. , 1991, American journal of human genetics.